Entering text into the input field will update the search result below

Endoscopy Equipment Market Worth $35.23 Billion: Wide Range Of Investment Opportunities For Market Players

Jul. 28, 2020 3:07 AM ETUcommune International Ltd (UK), OCPNF, SYK, BSX, MDT
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Summary

  • What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
  • What are the drivers, restraints, opportunities, and challenges in the Endoscopy Equipment Industry?
  • Who are the top 10 players operating in the global Endoscopy Equipment market?

The key factors driving the growth of endoscopy equipment market include growing demand for endoscopy, growing investments, funds, and grants, rising number of hospitals and growing hospital investments in endoscopy facilities, and technological advancements. However, unfavorable healthcare reforms in the US, and high cost of endoscopy procedures & equipment and limited reimbursement in developing countries are expected to restrain the growth of this market.

Endoscopy Equipment Market Dynamics: Impact Analysis

1. Growth in the Robotic Surgery Market

2. Growing Demand for Endoscopy

3. Growing Investments, Funds, and Grants

4. Rising Number of Hospitals and Growing Hospital Investments in Endoscopy Facilities

5. Technological Advancements

The global endoscopy equipment market to reach $35.23 billion by 2024 from an estimated $25.59 billion in 2019 at a CAGR of 6.6%.

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global Endoscopy Equipment market?

2. What are the drivers, restraints, opportunities, and challenges in the Endoscopy Equipment Industry?

3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?

4. What will be growth of Endoscopy Equipment in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Endoscope Segment:

Endoscopes accounted for the largest share of the market in 2018 and this segment is also estimated to grow at the highest CAGR during the forecast period. The dominant market share and growth rate of this segment can be primarily attributed to the rising adoption of minimally invasive procedures, increasing technological advancements and use of disposable endoscopes.

Download PDF Brochure:

Endoscopy Equipment Market

GI Endoscopy:

The GI endoscopy applications segment is expected to command the largest share of the market and grow at the highest CAGR during the forecast period. Rising geriatric population, improving healthcare infrastructure in developing countries, and increasing number of colonoscopy procedures performed in developed countries, are some factors supporting the growth of this applications segment.

Regional Growth Analysis:

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment accounted for the largest share of the market in 2018. The large share of North America in the global endoscopy equipment market is attributed to the favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing research activities to improve endoscopy, and the implementation of a new funding model for Canadian hospitals.

Request Sample Report:

Endoscopy Equipment Market

Key Market Players:

The major players in this market include Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm Corporation (Japan), Medtronic (Ireland), Hoya Corporation (Japan), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), and B. Braun (Germany).

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.